Full Breakdown
Former NFL Running Back Chris Johnson Announces ALS Diagnosis
6/30/2026, 12:00:18 AM
Core Event: Public Disclosure
On June 29 2026, former NFL running back Chris Johnson appeared on ABC’s *Good Morning America* with co-anchor Michael Strahan. Using a speech-generating device, Johnson confirmed a 2025 diagnosis of amyotrophic lateral sclerosis (ALS), a sporadic form with no known family history.
Background & Context: Career and Disease Overview
Johnson was the 24th overall pick in the 2008 NFL Draft by the Tennessee Titans. He earned three consecutive Pro Bowl selections (2008-2010), was the 2009 AP Offensive Player of the Year, and rushed for 2,006 yards that season—a record-setting 2,509 yards from scrimmage. He later played for the New York Jets (2014) and Arizona Cardinals (2015-2017) before retiring. ALS, also called Lou Gehrig’s disease, is a progressive neurodegenerative disorder that destroys motor neurons, leading to loss of muscle control, speech, swallowing and breathing. No cure exists; current therapies only modestly slow progression.
Timeline of Key Moments
- 2008: Drafted by the Titans (24th overall).
- 2009: Rushed 2,006 yards; set single-season scrimmage record (2,509).
- 2010-2012: Teammate Tim Shaw later diagnosed with ALS (2014).
- 2025: Johnson diagnosed with sporadic ALS at age 39.
- June 29 2026: Public announcement on *Good Morning America*.
Data & Statistics
- Career rushing yards: 9,651; rushing TDs: 55.
- Receiving: 307 catches, 2,255 yards, 9 TDs.
- Played 10 seasons, 130 games.
- Sporadic ALS accounts for ~90 % of cases; ~5,000 new U.S. diagnoses annually; median survival 3-5 years, with ~10 % living 10 + years.
Official Statements & Responses
Titans owner Amy Adams Strunk said Johnson’s “leadership on the field, in the locker room and in the Nashville community have written him permanently into the story of this franchise” and pledged full support. The Arizona Cardinals, New York Jets, and the NFL Players Association each issued messages of solidarity and encouragement. Neurologist Dr. Merit Cudkowicz noted Johnson’s enrollment in a clinical trial targeting inflammation and expressed optimism that his participation could advance ALS research.
Verbatim Quotes
- “There's no history of ALS in my family,” — Chris Johnson
- “My doctors believe my case is what's called sporadic ALS, which is actually how the vast majority of ALS cases happen.” — Chris Johnson
- “ALS has changed what my body can do, but it hasn't changed who I am ... Honestly, I don't know if you ever fully process it. At first, you're in shock. Then you realize you have two choices. You can give up, or you can fight. I chose to fight.” — Chris Johnson
- “I want people to know that I'm still me. ALS has changed what my body can do, but it hasn't changed who I am,” — Chris Johnson
Why It Matters / Impact
Johnson’s high-profile disclosure aims to raise ALS awareness, encourage early detection, and stimulate research funding. By linking a celebrated athlete to the disease, the announcement underscores the need for continued clinical trials and support networks for all affected individuals.
Conflicting Reports & Gaps
All sources agree the diagnosis occurred in 2025 and was announced in June 2026. Precise dates of diagnosis and detailed trial protocols remain undisclosed.
What’s Next
Johnson will remain in the anti-inflammatory clinical trial led by Dr. Cudkowicz and continue advocacy through public appearances and collaborations with ALS charities, providing updates as his treatment progresses.
